RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) released its quarterly earnings data on Friday. The company reported GBX (0.23) earnings per share for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 65.72% and a negative return on equity of 26.38%.

RUA Life Sciences Stock Down 7.4%

RUA Life Sciences stock traded down GBX 1.17 during midday trading on Friday, reaching GBX 14.58. The stock had a trading volume of 678,323 shares, compared to its average volume of 266,941. The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42. RUA Life Sciences has a 12 month low of GBX 10.42 and a 12 month high of GBX 16.80. The company has a fifty day moving average price of GBX 13.06 and a two-hundred day moving average price of GBX 12.02. The company has a market capitalization of £9.05 million, a P/E ratio of -2.61 and a beta of 1.21.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.